Covered recipient · General Payments record
ANJULI K SUDA
Allopathic & Osteopathic Physicians Pediatrics
General Payments · PY2018–2024
$4,535.24
- Reported across 282 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $272.31 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $51.09 | 2 |
| Cranial Technologies, Inc | $44.82 | 3 |
| Lilly USA, LLC | $33.76 | 2 |
| MannKind Corporation | $32.17 | 2 |
| Amgen Inc. | $31.00 | 2 |
| PFIZER INC. | $28.96 | 2 |
| SANOFI PASTEUR INC. | $20.11 | 1 |
| IBSA Pharma Inc. | $15.36 | 1 |
| Novo Nordisk AS | $15.04 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $22.92 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125077902 | CMS |
| Abbott Laboratories | $28.17 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125077904 | CMS |
| Amgen Inc. | $15.00 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111718351 | CMS |
| Amgen Inc. | $16.00 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111718353 | CMS |
| Cranial Technologies, Inc | $18.72 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082226510 | CMS |
| Cranial Technologies, Inc | $19.43 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082226512 | CMS |
| Cranial Technologies, Inc | $6.67 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082226508 | CMS |
| IBSA Pharma Inc. | $15.36 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142979825 | CMS |
| Lilly USA, LLC | $16.84 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136044606 | CMS |
| Lilly USA, LLC | $16.92 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136043194 | CMS |
| Mannkind Corporation | $14.91 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145850155 | CMS |
| Mannkind Corporation | $17.26 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145850157 | CMS |
| Novo Nordisk Inc | $15.04 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097149686 | CMS |
| PFIZER INC. | $14.45 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131116413 | CMS |
| PFIZER INC. | $14.51 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131064394 | CMS |
| SANOFI PASTEUR INC. | $20.11 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128732404 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.